Buy Generic Semaglutide Tablets
Sale!
Buy Generic Semaglutide Tablets

Buy Generic Semaglutide Tablets Cheap Price

Original price was: $70.00.Current price is: $60.00.

Description

what does semaglutide do?

Semaglutide is a medication primarily used to treat type 2 diabetes mellitus. It belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. Here’s what semaglutide does and how it works:

  1. Blood Sugar Control: Semaglutide helps lower blood sugar levels by mimicking the effects of glucagon-like peptide-1 (GLP-1), a hormone that increases insulin secretion from the pancreas when blood sugar levels are high. It also reduces the secretion of glucagon, a hormone that increases blood sugar levels.
  2. Slows Gastric Emptying: GLP-1 receptor agonists like semaglutide can slow down the rate at which the stomach empties, which helps control blood sugar levels by delaying the absorption of glucose from food into the bloodstream.
  3. Promotes Weight Loss: Semaglutide has been shown to promote weight loss in people with type 2 diabetes. This effect may be due to its ability to reduce appetite and food intake.
  4. Cardiovascular Benefits: Some studies suggest that semaglutide and other GLP-1 receptor agonists may have cardiovascular benefits beyond blood sugar control, such as reducing the risk of cardiovascular events like heart attacks and strokes in people with diabetes.

Semaglutide is typically administered as an injection under the skin (subcutaneous injection) or oral tablet. It is available in various formulations, including once-weekly and once-daily dosing options. It’s important to note that semaglutide should be used as part of a comprehensive treatment plan for type 2 diabetes, which may include lifestyle modifications such as diet and exercise, along with other medications as prescribed by a healthcare professional.

Indication And Usage of semaglutide

Semaglutide is a medication indicated for the treatment of type 2 diabetes mellitus in adults. It is used to improve glycemic control, which means it helps to lower blood sugar levels in people with type 2 diabetes.

Here are the key indications and usage of semaglutide:

  1. Type 2 Diabetes Mellitus: Semaglutide is prescribed to adults with type 2 diabetes mellitus to help control their blood sugar levels. It is typically used when diet and exercise alone do not provide adequate glycemic control, or when additional treatment is needed beyond oral diabetes medications.
  2. Monotherapy or Combination Therapy: Semaglutide can be used as monotherapy (alone) or in combination with other antidiabetic medications, such as metformin, sulfonylureas, sodium-glucose co-transporter 2 (SGLT-2) inhibitors, or insulin.
  3. Dosage Forms: Semaglutide is available in different dosage forms, including once-weekly injectable formulations (e.g., Ozempic) and once-daily oral tablets (e.g., Rybelsus).
  4. Administration: Injectable semaglutide is administered as a subcutaneous injection once weekly, typically on the same day each week. Oral semaglutide tablets are taken once daily, preferably at the same time each day.
  5. Adjunct to Lifestyle Modifications: Semaglutide treatment is usually part of a comprehensive diabetes management plan that includes lifestyle modifications, such as diet, exercise, and weight management.

It’s important for individuals prescribed semaglutide to follow their healthcare provider’s instructions carefully regarding dosage, administration, and monitoring of blood sugar levels. Additionally, regular follow-up appointments with healthcare professionals are essential to assess the effectiveness and safety of semaglutide therapy.

Pharmacology Of Semaglutide

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, a class of medications used in the management of type 2 diabetes mellitus. Here’s a breakdown of the pharmacology of semaglutide:
  1. Mechanism of Action: Semaglutide mimics the action of endogenous GLP-1, a hormone secreted by the intestine in response to food intake. GLP-1 plays a crucial role in regulating blood sugar levels by stimulating insulin secretion from pancreatic beta cells in a glucose-dependent manner. Semaglutide activates GLP-1 receptors in pancreatic beta cells, leading to increased insulin secretion and improved glucose uptake by peripheral tissues.
  2. Slows Gastric Emptying: GLP-1 receptor agonists like semaglutide also slow down the rate of gastric emptying, which helps to regulate postprandial (after-meal) blood sugar levels by delaying the absorption of glucose from the gastrointestinal tract.
  3. Suppression of Glucagon: Semaglutide suppresses the secretion of glucagon, a hormone that raises blood sugar levels by promoting the release of glucose from the liver. By inhibiting glucagon secretion, semaglutide helps to prevent excessive glucose production by the liver.
  4. Weight Loss Effects: Semaglutide has been associated with weight loss in patients with type 2 diabetes. This effect is believed to be mediated by the central nervous system, where GLP-1 receptors are also present, leading to reduced appetite and food intake.
  5. Pharmacokinetics: Semaglutide is administered subcutaneously (injected under the skin) in its therapeutic form. It has a long half-life, allowing for once-weekly dosing in its injectable formulation.
  6. Metabolism and Elimination: Semaglutide is primarily metabolized in the liver, and the metabolites are excreted mainly through the kidneys.
  7. Cardiovascular Effects: Some GLP-1 receptor agonists, including semaglutide, have shown cardiovascular benefits in patients with type 2 diabetes, including a reduction in the risk of major adverse cardiovascular events (such as heart attacks, strokes, and cardiovascular death).

Overall, semaglutide’s pharmacological actions contribute to improved glycemic control, weight loss, and potential cardiovascular benefits in patients with type 2 diabetes mellitus. As with any medication, it’s essential to use semaglutide under the guidance of a healthcare professional and to adhere to prescribed dosages and monitoring protocols.

Dosage And Administration

Semaglutide is available in both injectable and oral formulations. Here’s a general overview:
  1. Injectable Semaglutide (e.g., Semaglo Injection):
    • Injectable semaglutide is administered subcutaneously (under the skin) once weekly.
    • The recommended starting dose is usually 0.25 mg once weekly for 4 weeks.
    • After 4 weeks, the dose is typically increased to 0.5 mg once weekly, which is the maintenance dose for most patients.
    • Some patients may benefit from further dose escalation to 1 mg once weekly based on individual response and tolerability.
    • Semaglutide should be administered on the same day each week, at any time of the day, with or without meals.
    • The injection site should be rotated to different areas (e.g., abdomen, thigh, upper arm) to minimize the risk of injection site reactions.
  2. Oral Semaglutide (e.g., Semaglo tablet):
    • Oral semaglutide comes in tablet form and is taken by mouth once daily.
    • The recommended starting dose is typically 3 mg once daily for the first 30 days.
    • After 30 days, the dose is increased to 7 mg once daily for maintenance therapy.
    • Some patients may require further dose escalation to 14 mg once daily based on individual response and tolerability.
    • Oral semaglutide should be taken on an empty stomach, preferably at least 30 minutes before the first meal, with no more than 4 ounces of plain water.
    • The tablet should be swallowed whole and should not be crushed or chewed.

It’s important for patients to follow their healthcare provider’s instructions carefully regarding the dosage and administration of semaglutide. Regular monitoring of blood sugar levels and other parameters may be necessary to assess treatment efficacy and safety. Patients should also be educated about potential side effects and instructed to seek medical attention if any adverse reactions occur. As with any medication, it’s crucial to use semaglutide as prescribed and to maintain regular follow-up appointments with a healthcare professional.

Warnings And Precautions

  1. Risk of Thyroid C-Cell Tumors: Semaglutide has been associated with an increased risk of thyroid C-cell tumors in rodents. It is not known whether semaglutide causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans. Therefore, semaglutide should not be used in patients with a personal or family history of MTC, or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
  2. Pancreatitis: Acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis, has been reported in patients treated with GLP-1 receptor agonists such as semaglutide. Patients should be informed of the signs and symptoms of pancreatitis (persistent severe abdominal pain, sometimes radiating to the back, with or without vomiting) and instructed to discontinue semaglutide and seek medical attention if pancreatitis is suspected.
  3. Hypoglycemia: Semaglutide, like other antidiabetic medications, may increase the risk of hypoglycemia, especially when used in combination with insulin secretagogues (such as sulfonylureas) or insulin. Patients should be educated about the signs and symptoms of hypoglycemia and how to manage it, including the administration of glucose or glucagon if severe hypoglycemia occurs.
  4. Renal Impairment: Semaglutide should be used with caution in patients with renal impairment, as it may require dose adjustment based on renal function. Monitoring of renal function and dose adjustment may be necessary in patients with moderate to severe renal impairment or end-stage renal disease.
  5. Gastrointestinal Adverse Reactions: Semaglutide may cause gastrointestinal adverse reactions, including nausea, vomiting, diarrhea, and constipation. These symptoms are usually mild to moderate in intensity and may improve over time. Patients should be advised to report persistent or severe gastrointestinal symptoms to their healthcare provider.
  6. Heart Rate Increase: GLP-1 receptor agonists, including semaglutide, may increase heart rate. Patients with a history of heart disease or arrhythmias should be monitored closely for changes in heart rate during treatment with semaglutide.
  7. Injection Site Reactions: Injectable semaglutide may cause injection site reactions, including erythema, pruritus, and nodules. Patients should be instructed on proper injection techniques and advised to rotate injection sites to minimize the risk of injection site reactions.
  8. Hypersensitivity Reactions: Rare cases of hypersensitivity reactions, including anaphylaxis and angioedema, have been reported with semaglutide. Patients should be monitored for signs and symptoms of hypersensitivity reactions, and treatment should be discontinued if a hypersensitivity reaction occurs.

Patients should be counseled to read the medication guide provided with semaglutide and to report any adverse reactions or concerns to their healthcare provider. It’s essential for healthcare professionals to assess the individual risks and benefits of semaglutide therapy in each patient and to closely monitor patients for potential adverse effects during treatment.

Semaglutide Side Effects

Semaglutide, like all medications, can cause side effects in some individuals. Common side effects associated with semaglutide use include:
  1. Nausea: Nausea is one of the most commonly reported side effects of semaglutide. It may occur especially during the initial weeks of treatment but tends to diminish over time.
  2. Vomiting: Some patients may experience vomiting as a side effect of semaglutide therapy, particularly during the early stages of treatment.
  3. Diarrhea: Diarrhea can occur as a side effect of semaglutide. It is usually mild to moderate in severity and may resolve with continued treatment.
  4. Constipation: Conversely, some individuals may experience constipation while taking semaglutide.
  5. Abdominal Pain: Abdominal discomfort or pain may occur as a side effect of semaglutide. Patients should report any severe or persistent abdominal pain to their healthcare provider.
  6. Decreased Appetite: Semaglutide may lead to a decrease in appetite, which can contribute to weight loss in some patients.
  7. Hypoglycemia: While less common, semaglutide may increase the risk of hypoglycemia, especially when used in combination with other antidiabetic medications such as sulfonylureas or insulin.
  8. Injection Site Reactions: For the injectable formulation of semaglutide, injection site reactions such as redness, swelling, or itching may occur. These reactions are usually mild and transient.
  9. Headache: Some individuals may experience headaches while taking semaglutide.
  10. Fatigue: Fatigue or tiredness can occur as a side effect of semaglutide treatment.
  11. Increased Heart Rate: In some cases, semaglutide may lead to an increase in heart rate. Patients with a history of heart disease or arrhythmias should be monitored closely for changes in heart rate during treatment.

It’s essential for patients to discuss any side effects they experience with their healthcare provider. While most side effects of semaglutide are mild to moderate and transient, some may require medical attention or adjustments to the treatment plan. Additionally, patients should be aware of potential allergic reactions or serious adverse effects and seek prompt medical attention if they occur.

Use In Specific Populations

Semaglutide, like many medications, may have specific considerations for use in certain populations. Here’s an overview of its use in specific populations:
  1. Pregnancy: Semaglutide is not recommended for use during pregnancy. Adequate and well-controlled studies in pregnant women have not been conducted. Animal studies have shown adverse effects on the fetus, including skeletal malformations, when semaglutide was administered during pregnancy. Women who become pregnant while taking semaglutide should be advised to discontinue the medication and consult their healthcare provider.
  2. Breastfeeding: It is not known whether semaglutide is excreted in human breast milk. Because of the potential for adverse effects on the nursing infant, a decision should be made whether to discontinue breastfeeding or discontinue the medication, taking into account the importance of the drug to the mother.
  3. Pediatric Use: The safety and effectiveness of semaglutide have not been established in pediatric patients
  4. Geriatric Use: Clinical studies of semaglutide did not include sufficient numbers of patients aged 65 and over to determine whether they respond differently from younger patients. No overall differences in safety or effectiveness were observed between these patients and younger patients, but greater sensitivity of some older individuals cannot be ruled out.
  5. Renal Impairment: Semaglutide should be used with caution in patients with renal impairment. Dose adjustment may be necessary based on the degree of renal impairment. Monitoring of renal function is recommended in patients with moderate to severe renal impairment or end-stage renal disease.
  6. Hepatic Impairment: Semaglutide has not been studied in patients with hepatic impairment. However, GLP-1 receptor agonists are not primarily metabolized by the liver, so dose adjustment is not expected to be necessary in patients with hepatic impairment.
  7. Ethnic/Racial Groups: Semaglutide’s safety and efficacy have been studied across various ethnic and racial groups, and no clinically significant differences have been observed based on race or ethnicity.

Overdose

An overdose of semaglutide can potentially lead to hypoglycemia (low blood sugar) and gastrointestinal side effects. Here’s what you should know about semaglutide overdose:

  1. Hypoglycemia: Semaglutide, like other medications used to treat diabetes, can cause hypoglycemia, especially if taken in excessive doses or if combined with other antidiabetic medications. Symptoms of hypoglycemia include sweating, shakiness, dizziness, hunger, confusion, headache, irritability, rapid heartbeat, and in severe cases, loss of consciousness or seizures.
  2. Gastrointestinal Side Effects: Overdose of semaglutide may exacerbate gastrointestinal side effects such as nausea, vomiting, diarrhea, and abdominal discomfort.

If you suspect an overdose of semaglutide or experience symptoms of hypoglycemia, it’s essential to seek immediate medical attention. Here are some steps to take:

  • Check Blood Sugar: If you are able to, check your blood sugar levels. If they are low (typically below 70 mg/dL), consume a fast-acting carbohydrate source such as glucose tablets, juice, or soda to raise your blood sugar.
  • Contact Healthcare Provider or Emergency Services: Inform your healthcare provider or call emergency services immediately. Provide details about the overdose, including the amount of medication taken and any symptoms experienced.
  • Follow Medical Advice: Follow the instructions provided by healthcare professionals. Depending on the severity of the overdose and symptoms, treatment may involve administration of glucose, close monitoring of blood sugar levels, and supportive care.
  • Avoid Driving or Operating Machinery: If you experience symptoms of hypoglycemia, avoid driving or operating machinery until your blood sugar levels have stabilized.

It’s important to store semaglutide and other medications safely out of reach of children and pets to prevent accidental ingestion. Additionally, always follow your healthcare provider’s instructions regarding dosage and administration of semaglutide to minimize the risk of overdose.

Pharmaceutical Information

Storage

Semaglutide tablets should be stored at a controlled room temperature between 20°C to 25°C (68°F to 77°F). The tablets should be protected from moisture and light. It is important to keep the tablets in the original packaging until ready to use to protect them from moisture and light.

How Supplied

Semaglutide tablets are supplied as film-coated tablets for oral administration. The tablets are available in two strengths: 3 mg and 7 mg. Each commerical box contains 10 tablets. The tablets are supplied in a Alu-Alu blister pack.

How To Buy Generic Semaglutide Tablets In Cheap Price

There is no USA FDA generic semaglutide in the market. But some developing countries are allowed to manufacture generic medicine and use for there populations. Bangladesh is one of the country where generic semaglutide is available. Bangladesh government allows some pharmaceuticals companies to manufacture semaglutide. Ziska pharmaceuticals limited is one of them.  You can buy generic semaglutide (Semaglo) 3 mg and 7 mg in affordable cost from 100meds. Contact us to know more details.

Reviews

There are no reviews yet.

Be the first to review “Buy Generic Semaglutide Tablets Cheap Price”

Open chat
1
Need Help?